Singular Genomics Systems, Inc.
Singular Genomics Systems, Inc. (OMIC) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 81 transactions totaling $35.6M, demonstrating a bullish sentiment with $34.9M in net insider flow. The most recent transaction on Sep 18, 2024 involved a purchase of 32,000 shares valued at $550.7K.
OMIC Insider Activity Summary
Who Is Buying OMIC Stock?
No significant insider buying has been recorded for OMIC in the recent period.
Who Is Selling OMIC Stock?
No significant insider selling has been recorded for OMIC in the recent period.
Is Singular Genomics Systems, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for OMIC is bullish with an Insider Alignment Score of 99/100 and a net flow of $34.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
OMIC Frequently Asked Questions
Understanding OMIC Insider Activity
Insider trading at Singular Genomics Systems, Inc. (OMIC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading OMIC stock, having executed 81 transactions in the past 90 days. The most active insider is James E. Flynn (Executive), who has made 5 transactions totaling $53.3M.
Related Tools
Track Singular Genomics Systems, Inc. Insider Activity
Get notified when executives and directors at OMIC file new Form 4 transactions